Olimel N12e (Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin)

Olimel N12e is used as an intravenous amino acid solution to support protein metabolism in several clinical situations.

• Total parenteral nutrition (TPN): supplies essential amino acids to maintain nitrogen balance when enteral feeding is not possible.
• Critical care patients: provides rapid nutritional support during acute illness or trauma.
• Post‑operative recovery: aids wound healing and tissue repair when oral intake is limited.

• The amino acids in Olimel N12e are directly available for protein synthesis, serve as precursors for neurotransmitters and metabolic intermediates, and help restore nitrogen balance. By delivering a balanced profile of essential and non‑essential amino acids intravenously, the formulation bypasses gastrointestinal absorption and supports cellular growth, immune function, and tissue repair in patients unable to eat or absorb nutrients normally.

Common Side Effects

• Infusion site erythema or pain: mild local irritation at the catheter site.
• Hyperglycemia: transient rise in blood glucose, especially in diabetic patients.
• Nausea or vomiting: gastrointestinal discomfort during or after infusion.
• Electrolyte shifts: mild changes in potassium or sodium levels.
• Fever or chills: reaction to the infusion process.
• Headache: transient discomfort during administration.

Serious or Rare Side Effects

• Anaphylactic reaction: severe hypersensitivity requiring immediate medical intervention.
• Metabolic acidosis: significant pH imbalance due to rapid amino acid metabolism.
• Hepatic dysfunction: elevated liver enzymes in susceptible individuals.
• Hyperammonemia: excess ammonia accumulation, particularly in liver disease.
• Renal failure: worsening kidney function in patients with pre‑existing renal impairment.
• Sepsis related to contamination: infection risk if aseptic technique is breached.

When using Olimel N12e, clinicians should consider several safety measures.

• Assess renal function: adjust infusion volume in patients with impaired kidneys.
• Monitor blood glucose: amino acid load may affect glycemic control.
• Check for allergies: avoid in individuals with known hypersensitivity to any component.
• Use aseptic technique: prevent microbial contamination during preparation and administration.
• Limit infusion rate: follow institutional protocols to avoid metabolic complications.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Olimel N12e may interact with other therapies; awareness of the level of interaction helps guide monitoring.

Major Interactions (Avoid)

• Concurrent high‑dose amino acid solutions: risk of hyperammonemia.
• Renal replacement therapy: altered clearance may require dose adjustment.
• Insulin therapy: potential for severe hypoglycemia if glucose not monitored.

Moderate Interactions (Monitor Closely)

• Electrolyte supplements: monitor for potassium or sodium imbalances.
• Diuretics: may affect fluid and electrolyte balance during infusion.
• Corticosteroids: can increase protein catabolism, influencing amino acid requirements.